Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -17.137% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Fc1ccccc1/C=N/Nc1nn[nH]n1
b) CC1(C)Cc2c(C#N)c(NCCN3CCOCC3)nc(-c3ccccc3)c2CO1
Answer: b. CC1(C)Cc2c(C#N)c(NCCN3CCOCC3)nc(-c3ccccc3)c2CO1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C)Cc2c(C#N)c(NCCN3CCOCC3)nc(-c3ccccc3)c2CO1
CC1(C)Cc2c(C#N)c(NCCN3CCOCC3)nc(-c3ccccc3)c2CO1
3,3-dimethyl-6-(2-morpholin-4-ylethylamino)-8-phenyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile